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A large body of epidemiologic evidence sug-
gests associations between ambient air pollu-
tion and cardiovascular mortality and
morbidity (Peters and Pope 2002; Pope et al.
2004). All of these studies focus on events
occurring at a late stage of vascular disease
processes. The impact of air pollution on the
underlying preclinical conditions remains
poorly understood. We hypothesize that cur-
rent levels of ambient particulate matter (PM)
up to 2.5 µm in aerodynamic diameter
(PM2.5) may contribute to atherosclerosis,
leading to subclinical anatomical changes that
play a major role in cardiovascular morbidity
and mortality later in life. Animal studies sup-
port our hypothesis by showing that inhalation
of ambient PM promotes oxidative lung dam-
age, including alveolar and systemic inﬂamma-
tory responses (Becker et al. 1996; Dye et al.
2001; Fujii et al. 2002; Goto et al. 2004; Suwa
et al. 2002; van Eeden et al. 2001).
We investigated the association between
residential ambient PM2.5 and carotid artery
intima-media thickness (CIMT) using pre-
randomization baseline data from two recent
clinical trials conducted in Los Angeles,
California (Hodis et al. 2002). CIMT is a
well-established quantitative measure of
generalized atherosclerosis that correlates well
with all of the major cardiovascular risk fac-
tors, with coronary artery atherosclerosis, and
with clinical cardiovascular events (Mack et al.
2000). It is an established tool for investigating
the contribution of long-term exposures such
as smoking or passive smoking to subclinical
stages of atherosclerosis at any given age (Diez-
Roux et al. 1995; Howard et al. 1994, 1998).
This is the ﬁrst study to assess the association
of atherosclerosis with air pollution.
Materials and Methods
Population and health assessment. We used
baseline health data from two randomized,
double-blind, placebo-controlled clinical trials
conducted at the University of Southern
California Atherosclerosis Research Unit
(Hodis et al. 2002). The Vitamin E
Atherosclerosis Progression Study (VEAPS)
investigated the effects of vitamin E on the
progression of atherosclerosis measured by
CIMT. The B-Vitamin Atherosclerosis
Intervention Trial (BVAIT) focused on the
effect of vitamin B supplements on the pro-
gression of atherosclerosis (trial in progress).
Baseline assessment in both trials included
CIMT measured between 1998 and 2003
using the same standardized methods
(Hodis et al. 2002; Selzer et al. 1994, 2001).
Recruitment of volunteers occurred over the
entire Los Angeles Basin, covering a geo-
graphic area of approximately 64,000 km2.
Eligible subjects for the VEAPS trial
(n = 353) were men and women ≥ 40 years of
age with slightly increased LDL cholesterol
(≥ 3.37 mmol/L) but with no clinical signs or
symptoms of cardiovascular disease (CVD)
(Hodis et al. 2002). Subjects with diabetes,
diastolic blood pressure > 100 mm Hg, thyroid
disease, serum creatinine > 0.065 mmol/L, life-
threatening diseases, or high alcohol intake
were excluded.
BVAIT (n = 506) had a similar design to
that of VEAPS. Men and women > 40 years
of age were prescreened to meet study criteria
(fasting plasma homocysteine ≥ 8.5 µmol/L;
postmenopausal for women; no evidence of
diabetes, heart disease, stroke, or cancer).
Subjects were excluded on the basis of any
clinical signs or symptoms of CVD, diabetes
or fasting serum glucose ≥ 140 mg/dL, triglyc-
eride levels ≥ 150 mg/dL, serum creatinine
> 1.6 mg/dL, high blood pressure, untreated
thyroid disease, life-threatening disease with
prognosis < 5 years, or high alcohol intake.
Thus, our study included “healthy” subjects
with biomarkers (elevated LDL cholesterol or
homocysteine) that suggested an increased risk
of future CVDs (n = 859). Fifty-eight subjects
were excluded in the exposure assignment
process because they lived outside the area
with PM2.5 data. Three subjects had missing
data in at least one of the covariates used in
the models. Our total sample consisted of 798
participants.
Health measures, including CIMT. Our
main outcome of interest is CIMT. In both
trials, high-resolution B-mode ultrasound
images of the right common carotid artery
were obtained before the intervention (base-
line) with a 7.5-MHz linear array transducer
attached to an ATL Ultramark-4 Plus
Ultrasound System (Ultramark, Bothell, WA).
We used this baseline CIMT measurement as
the outcome. Details of this highly repro-
ducible method are published (Hodis et al.
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Associations have been found between long-term exposure to ambient air pollution and cardiovascular
morbidity and mortality. The contribution of air pollution to atherosclerosis that underlies many
cardiovascular diseases has not been investigated. Animal data suggest that ambient particulate matter
(PM) may contribute to atherogenesis. We used data on 798 participants from two clinical trials to
investigate the association between atherosclerosis and long-term exposure to ambient PM up to 2.5
µm in aerodynamic diameter (PM2.5). Baseline data included assessment of the carotid intima-media
thickness (CIMT), a measure of subclinical atherosclerosis. We geocoded subjects’ residential areas to
assign annual mean concentrations of ambient PM2.5. Exposure values were assigned from a PM2.5
surface derived from a geostatistical model. Individually assigned annual mean PM2.5 concentrations
ranged from 5.2 to 26.9 µg/m3 (mean, 20.3). For a cross-sectional exposure contrast of 10 µg/m3
PM2.5, CIMT increased by 5.9% (95% conﬁdence interval, 1–11%). Adjustment for age reduced the
coefﬁcients, but further adjustment for covariates indicated robust estimates in the range of 3.9–4.3%
(p-values, 0.05–0.1). Among older subjects (≥ 60 years of age), women, never smokers, and those
reporting lipid-lowering treatment at baseline, the associations of PM2.5 and CIMT were larger with
the strongest associations in women ≥ 60 years of age (15.7%, 5.7–26.6%). These results represent
the ﬁrst epidemiologic evidence of an association between atherosclerosis and ambient air pollution.
Given the leading role of cardiovascular disease as a cause of death and the large populations
exposed to ambient PM2.5, these findings may be important and need further confirmation.
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(2005). doi:10.1289/ehp.7523 available via http://dx.doi.org/ [Online 22 November 2004]2002; Selzer et al. 1994, 2001). Blood pres-
sure, height, and weight were measured with
standard procedures.
The baseline questionnaires included an
assessment of all major CVD risk factors and
covariates, including clinical events, diet, use
of prescription medications, physical activity,
current and past smoking and passive smok-
ing, and vitamin supplements. Age, educa-
tion, and other sociodemographic factors
were available for each subject. Fasting blood
samples were also drawn for lipid measure-
ments. Data used in our analyses were col-
lected with the same tools in both trials.
Exposure assignment. To assess exposure
we chose a novel approach derived from a
geographic information system (GIS) and
geostatistics. This method allows for assign-
ment of long-term mean ambient concentra-
tions of PM2.5 to the ZIP code area of each
subject’s residential address (Künzli and Tager
2000). The resulting surface of PM2.5 covered
the entire Los Angeles metropolitan area. The
surface is derived from a geostatistical model
and data from 23 state and local district mon-
itoring stations (during 2000). These moni-
tors are located across the Los Angeles region
to characterize urban levels of pollution. To
assign exposure, PM2.5 data were interpolated
using a combination of a universal kriging
model with a quadratic drift and a multi-
quadric radial basis function model (Bailey
and Gatrell 1995; Burrough and McDonnell
1998). We averaged the two surfaces based on
25-m grid cells. Examination of errors from
the universal model showed that > 50% of the
study area had assigned values within 15% of
monitored concentrations, whereas 67% were
within 20%. The larger errors were on the
periphery of our study area, where the density
of study participants was the lowest. We
linked the ZIP code centroids of each subject
with the exposure surface through a geocod-
ing database [Environmental Systems
Research Institute (ESRI) 2004]. Figure 1
illustrates the PM2.5 surface with the geolo-
cated ZIP codes. Individually assigned PM2.5
data had a range from 5.2 to 26.9 µg/m3
(mean, 20.3), thus exceeding the range
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Figure 1. ZIP code locations of the study population geocoded on the PM2.5 surface, modeled with 2000
PM2.5 data, and distribution of individually assigned concentrations.
Table 2. Percent change (and 95% CI) in CIMT (µm) associated with a 10 µg/m3 change in ambient outdoor PM2.5 concentration at the residential ZIP code in the
total population (n = 798).a
Modela  Total sample (798) Females ≥ 60 years (186) Lipid-lowering therapy (109)
(with adjustment factors in the model) Percent change p-Value Percent change p-Value Percent change p-Value
None (unadjusted estimate) 5.9 (1.0–10.9) 0.018 19.2 (8.8–30.5) 0.001 15.8 (2.1–31.2) 0.024
Age, sex, education, incomeb 4.4 (0.0–9.0) 0.056 15.7 (5.7–26.6) 0.002 13.3 (0–28.5) 0.051
All above plus active and passive 4.2 (–0.2–8.9) 0.064 13.8 (4.0–24.5) 0.002 13.3 (–0.3–28.8) 0.060
smoking, multivitamins, alcohol
aUnadjusted association (crude model) and estimates from two multivariate models; 95% CIs of the estimates are shown in parentheses. The relative effects are based on a linear model
with log intima-media thickness as dependent variable. bFactors with univariate associations with both, CIMT and PM2.5.
Table 1. Description of assigned exposure (outdoor concentration in 2000) and CIMT, and main characteristics of the study population at the time of baseline
measurements in the total sample, men, women, women ≥ 60 years of age, and subjects under lipid-lowering therapy.
Females Lipid-lowering
Characteristic Total sample (n = 798) Males (n = 443) Females (n = 355) ≥ 60 years (n = 186) therapy (n = 109)
PM2.5 (µg/m3) 20.3 ± 2.6 20.1 ± 2.7 20.5 ± 2.4 20.7 ± 2.3 20.0 ± 2.5
Ozone (ppb, annual mean of daily maximum) 89.2 ± 17.9 89.6 ± 18.5 88.8 ± 17.3 87.1 ± 17.2 88.5 ± 18.6
CIMT (µm) 755 ± 148 767 ± 166 740 ± 118 775 ± 120 788 ± 140
Age (years) 59.2 ± 9.8 58.3 ± 10.3 60.4 ± 8.9 67.3 ± 5.3 63.3 ± 10.0
Diastolic blood pressure (mm Hg) 77.8 ± 9.2 79.2 ± 8.8 75.9 ± 9.3 74.8 ± 9.5 78.1 ± 8.9
Systolic blood pressure (mm Hg) 127.2 ± 16.3 126.7 ± 16.0 127.8 ± 16.6 130.5 ± 16.7 130.9 ± 16.2
LDL cholesterol (mg/dL) 137.9 ± 29.5 137.0 ± 30.9 139.0 ± 27.6 136.4 ± 26.9 125.7 ± 33.7
White (%) 67.3 67.7 66.8 65.0 69.7
Smoking status (%)
Never smokers 62.9 62.8 63.1 62.9 53.2
Former smokers 33.2 33.4 33.0 33.3 44.0
Current smokers 3.8 3.6 3.9 3.8 2.8
ETS at home (%) 33.5 21.9 47.9 55.4 37.5
Lipid-lowering therapy (%) 13.7 15.3 11.5 15.1 100
Antihypertensive prescriptions (%) 26.2 26.6 25.6 33.3 42.2
ETS, environmental tobacco smoke. Data are mean ± SD except where indicated.observed across 156 metropolitan areas used
in the largest cohort study of air pollution and
mortality (Pope et al. 2002). All models were
implemented with ArcScript from ESRI
(Redlands, CA).
Statistical analyses. We tested the uni-
variate and multivariate associations between
CIMT and ambient PM2.5 using linear regres-
sion analyses. Extensive residual diagnostics
indicated some heteroskedasticity, which was
rectified with the natural log-transformed
CIMT. We adjusted for factors that were sta-
tistically associated with both CIMT and
ambient PM2.5 (age, male sex, low education,
and low income). Next, we expanded the
models using covariates that were associated
with either PM2.5 or CIMT, including indica-
tor variables for current second-hand smoke
exposure and current and former personal
smoking. We then added covariates that play a
role in atherosclerosis such as blood pressure,
LDL cholesterol, or proxy measures such as
reporting treatment with antihypertensives or
lipid-lowering medications at study entry.
These factors may affect the pathophysiologic
pathways linking air pollution exposure and
atherosclerosis (Ross 1999); thus, such models
may overadjust the coefﬁcients. We chose this
conservative approach to test the sensitivity of
the effect estimates under a broad range of
model assumptions.
There is increasing evidence that host
factors such as age, sex, or underlying disease
and risk profiles may modify the effects of
air pollution (Pope et al. 2002; Zanobetti
and Schwartz 2002). Furthermore, the find-
ing of atherosclerosis in PM-exposed rabbits
was based on a hyperlipidemic trait (Suwa
et al. 2002). Therefore, we also stratified by
sex, age (< 60 years, ≥ 60 years), smoking
status, and lipid-lowering drug therapy.
Results
Table 1 summarizes the main characteristics of
the study population and among main sub-
groups. Table 2 presents the percent change in
CIMT in association with a 10 µg/m3 contrast
in ambient PM2.5 concentrations for three
cross-sectional regression models. The unad-
justed model indicates a 5.9% [95% confi-
dence interval (CI), 1–11%] increase in CIMT
per 10 µg/m3 PM2.5. For the observed contrast
between lowest and highest exposure
(20 µg/m3 PM2.5), this corresponds to a 12.1%
(2.0–23.1%) increase in CIMT. The only
covariate with a substantial effect on the point
estimate was age, which reduced the effect
from 5.9 to 4.3% (0.4–9%) per 10 µg/m3
PM2.5. This change agrees with the age-related
effect modiﬁcation. Otherwise, effect estimates
across the models remained robust, in the
range of 3.9–4.3% with p-values from 0.05 to
0.1. To corroborate the exposure–response
relationship, we also categorized PM2.5 levels
into quartiles. Figure 2 shows the adjusted
mean CIMT across these four groups of equal
sample size at the mean levels of the covariates
(age, sex, education, and income). The trend
across the exposure groups was statistically sig-
niﬁcant (p = 0.041). The unadjusted means of
CIMT among these quartiles of exposure were
734, 753, 758, and 774 µm, respectively.
The associations between CIMT and
PM2.5 were substantially stronger among
109 subjects reporting lipid-lowering medica-
tion at study entry, both in men and in women
(Table 2, Figure 3). The crude effect reached
15.8% (2–31%) per 10 µg/m3 PM2.5, with
adjusted values ranging between 12 and 16%.
Despite the small sample size, p-values of all
models were mostly < 0.1 and often < 0.05.
Results also suggest signiﬁcant age and sex
interactions, with much larger effects in
women and in the older age group (Figure 3).
Effect estimates in women were statistically
signiﬁcant and typically in the range of 6–9%
per 10 µg/m3 PM2.5. Associations were
strongest among women ≥ 60 years of age
(n = 186), leading to crude estimates of
19.2% (9–31%). Adjusted coefﬁcients ranged
from 14 to 19%, being statistically signiﬁcant
in all models and sensitivity analyses.
Among never smokers (n = 502), the effect
estimate reached 6.6% (1.0–12.3%). The esti-
mate was small and not signiﬁcant in current
(n = 30) and former smokers (n = 265).
Discussion
Our study presents the first evidence for an
association between CIMT and long-term
exposure to ambient air pollution. As recently
reviewed in a statement of the American Heart
Association (Brook et al. 2004) substantial epi-
demiologic and experimental evidence suggests
a contribution of ambient air pollutants on
cardiovascular mortality and morbidity.
However, these studies focus on acute and sub-
acute effects on cardiac autonomic function,
inflammatory or thrombogenic markers,
arrhythmia, myocardial infarction, cardio-
vascular hospital admission, and death. The
only outcome considered in long-term air pol-
lution studies has been mortality. The relative
risks for acute effects on mortality have been
substantially smaller than those observed for
long-term associations (Pope et al. 2002;
Samet et al. 2000). As shown previously,
cohort studies are capable of capturing acute
and chronic effects of air pollution on the
course of diseases that ultimately lead to pre-
mature death (Künzli et al. 2001). In contrast,
time-series and panel studies investigate only
the associations of event occurrence with the
most recent exposure (Künzli et al. 2001).
Article | Air pollution and atherosclerosis
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Figure 2. Mean CIMT ± 1 SE among quartiles of the
PM2.5 distribution. The y-axis shows mean CIMT lev-
els at the population average of the adjustment
covariates (age, sex, education, and income). The
ﬁrst quartile is the reference group.
Figure 3. Percent difference and 95% CI in CIMT associated with a 10 µg/m3 contrast in ambient PM2.5 in all
subjects and in subgroups. Lipid-LT, lipid-lowering therapy. All estimates are based on the cross-sectional
linear model with log intima-media thickness as the dependent variable and home outdoor PM2.5 as the
independent variable, adjusted for sex, age, education, and income. Numbers in parentheses are numbers
of subjects per group. Data are ordered by size of point estimate; the null effect line is indicated by a dash.Thus, if air pollution has both acute and
cumulative long-term effects, one expects
larger mortality coefﬁcients in cohort studies.
CIMT reﬂects long-term past exposure; thus,
we provide the ﬁrst evidence for chronic effects
of air pollution on atherogenesis that may in
part explain the above mentioned discrepancy
between acute and long-term risk estimates
(Pope et al. 2002; Samet et al. 2000).
There are several major aspects to be con-
sidered in the interpretation of this new ﬁnd-
ing, mainly the strength in the exposure
assignment, the limited evidence for bias, the
differences in effects within subgroups, and
plausibility.
Exposure assignment. The individual resi-
dence-based assignment of exposure represents
a substantial improvement over most studies
that have relied on central monitors or on
binary road buffers combined with basic inter-
polation (Hoek et al. 2002; Pope et al. 2004).
As a sensitivity analysis, we used weighted
least-squares models with the weights speciﬁed
as the inverse of the standard errors from the
universal kriging model to down-weight esti-
mates with larger error. In addition, we imple-
mented models based solely on the universal
kriging estimate. In both instances results were
robust and similar to what we found with our
main model.
Time–activity studies show that people
spend most of their time in or around home,
and our restriction of exposure assessment on
residential address captures the most relevant
part of exposure (Leech et al. 2002). PM2.5
generally displays spatially homogeneous dis-
tributions across small areas such as neighbor-
hoods and blocks, and as a result, the ambient
conditions at the ZIP code centroid likely
reflect the levels expected at home outdoors
(Roosli et al. 2000). PM2.5 of outdoor origin
will also penetrate indoors, and correlations
between long-term outdoor PM concentra-
tions and indoor levels of PM from outdoor
origin is high (Sarnat et al. 2000). Exposure
to ambient air pollution while working and
during commute are not included in our
exposure term but are considered to be a rele-
vant source of exposure (Riediker et al. 2003).
Although most likely a random misclassiﬁca-
tion with biases toward the null, the errors
may affect subgroups differently, thus
explaining part of the observed interactions.
In Los Angeles, no clear trends have been
observed in PM2.5 concentrations over the past
5–10 years. The year 2000 surface characterizes
the prevailing mean PM2.5 concentrations
across several years and can be considered a
measure of long-term past exposure. This year
also sits in the middle of the baseline recruit-
ment period. Overall, the various limitations
in our exposure assignment may add some
random error, biasing results toward weaker
associations (Thomas et al. 1993).
We also assigned ambient ozone to ZIP
code centroids. Inclusion of ozone in the
models had no impact on the PM2.5 coeffi-
cients or the SEs. Ozone and PM2.5 were not
correlated (r = –0.17), and the PM2.5 esti-
mates were not substantially different in low-
and high-ozone regions. The estimates of
association for ozone were positive but not
statistically signiﬁcant and much smaller than
for PM2.5. This ﬁnding must be put in con-
text of the speciﬁc challenges in determining
long-term exposure to ozone, which are sub-
stantially different than in the case of PM
exposure. In contrast to PM2.5 from outdoor
origin, ambient ozone levels have lower corre-
lations with personal exposure (Avol et al.
1998; Sarnat et al. 2000, 2002); therefore, the
ability to detect effects of ozone will likely be
reduced due to greater misclassiﬁcation.
Biases. Our subjects were a nonrandom
sample of “healthy” volunteers with above-
average education, meeting strict inclusion
criteria for the two clinical trials. Although we
cannot exclude some systematic selection
biases affecting the cross-sectional data, it is
unlikely that subjects with preclinical signs of
atherosclerosis would have been more likely to
volunteer if they lived in more polluted areas.
Although the selection of subjects limits the
generalization to other populations, we do not
expect this to lead to over- or underestimating
the cross-sectional associations. The two trials
recruited subjects independently; thus, the
effects may be compared across trials to evalu-
ate the potential inﬂuence of selecting volun-
teers. The populations differed with regard to
age, smoking habits, baseline LDL and treat-
ment, blood pressure, active and passive smok-
ing, and other relevant factors; thus, the PM2.5
coefﬁcients were smaller and were not statisti-
cally significant in the VEAPS trial with its
younger population. However, after taking
these factors into account, the associations
with ambient PM2.5 were similar. For exam-
ple, among elderly women of VEAPS (n = 70)
and BVAIT (n = 116), the effect estimate
was 18.1% (–0.1 to 36.3.%) and 13.6%
(2.8–24.4.%), respectively. There is some evi-
dence for larger effects in subjects with cardio-
vascular risk factors, indicated by prescriptions
of lipid-lowering treatment. Our trials
excluded subjects with clinically manifest
CVDs. Moreover, if air pollution ampliﬁes sys-
temic inflammation among those prone to
atherosclerosis, exclusion of subjects with high
LDL may be a source of bias. One may expect
effect estimates in a less selected, less healthy
population to be larger than those reported.
The wealth of baseline data from these
clinical trials offered the opportunity to con-
trol for a broad array of covariates. Apart
from the effect of age adjustment, estimates
were robust to numerous combinations of
covariates, including income, education,
active and passive tobacco smoke, cardio-
vascular prescriptions, vitamin intake, and
physical activity. Uncontrolled or residual
confounding appears to be an unlikely expla-
nation for these results. Among women,
adjustment for hormone replacement thera-
pies did not affect the PM2.5 estimates.
In previous studies, we found that spatial
autocorrelation in the residuals could affect
the size and significance of pollution coeffi-
cients (Jerrett et al. 2003a). We investigated
spatial autocorrelation of the unstandardized
residuals. We assessed autocorrelation with
first-order, adjusted first-order, and second-
order spatial weight matrices based on nearest
neighbor contiguity, but we found no evi-
dence of spatial autocorrelation. This supports
the conclusion that the models supply efﬁcient
unbiased estimates (Jerrett et al. 2003b). As
part of our sensitivity analyses, we also derived
PM2.5 surfaces using different interpolations
and weighted least squares with weights equal
to the inverse of the standard error of the
exposure estimate. All approaches produced
very similar results.
Evidence for effect modiﬁcation. The data
suggest substantial interactions with age, sex,
smoking, and underlying cardiovascular risk
factors. Given the reduced sample size among
subgroups, the recruitment of volunteers, and
the cross-sectional nature of the data, it is difﬁ-
cult to fully explore the causes of the observed
modiﬁcations of associations and to establish
susceptibility proﬁles. If the exposure misclassi-
ﬁcations differed across subgroups, part of the
interactions may be explained by differential
exposure error. The sex and age difference
could also be an artifact due to measurement
error in the assigned exposure because time
spent in commuting and location of work
places may be different in men and women
and in the young and elderly. Empirical studies
on mobility suggest women have smaller activ-
ity spaces than men and younger groups,
meaning they tend to spend more time in and
around the home (Kwan and Lee 2004), and
the same is probably true of the elderly com-
pared with younger groups. Exposure measure-
ment error may be reduced in those spending
more time at home, leading to stronger effects
(Thomas et al. 1993). Moreover, differences in
statistical power may play a role as well; as
shown at least for the 25–40-year age range,
power to detect effects on CIMT is larger in
women than in men (Stein et al. 2004).
The ﬁnding that those reporting prescrip-
tions of lipid-lowering medications at baseline
showed stronger associations of CIMT with
PM2.5 merits further investigation. This result
agrees with the observed effects of PM on ath-
erosclerosis in experiments conducted in
hyperlipidemic rabbits (Goto et al. 2004; Suwa
et al. 2002). The systemic inﬂammatory and
atherogenic reaction in these rabbits was
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alveolar macrophages. In our study, being
under lipid-lowering therapy is an indicator for
risk proﬁles prone to atherogenesis. Those sub-
jects were mostly men (64%) and, on average,
older, more often active or passive smokers,
and almost twice as likely to report anti-
hypertensive treatment. The systemic response
to ambient PM may amplify and expand the
oxidation of LDL cholesterol among these sus-
ceptible subjects, consequently contributing to
injury in the artery wall (Goto et al. 2004; Ross
1999). Investigations of short-term effects of
ambient air pollution on mortality also suggest
that underlying risk profiles such as diabetes
may amplify susceptibility to ambient PM
(Zanobetti and Schwartz 2002), and similar
ﬁndings have been shown with smoking and
diabetes mellitus in association with CIMT
(Karim et al. 2005). To clarify the relevance of
lipid status, it would be interesting to investi-
gate our hypothesis among cohorts with
familial hypercholesteremia (Wiegman et al.
2004; Wittekoek et al. 1999).
As shown in Figure 3, the size of the point
estimate was larger among the older subjects.
Future research needs to clarify whether air
pollution contributes to atherosclerosis only
after a certain age or early on. Effects of air
pollution on lung development have been
observed during adolescence and may be a
result of both pulmonary and chronic sys-
temic inﬂammatory effects (Gauderman et al.
2002); thus, it is conceivable that atherogenic
responses may occur early in life. The age
dependence of the effects may also be codeter-
mined by genetic factors (Humphries and
Morgan 2004; Ross 1999).
We also observed larger effects in women.
If other cardiovascular risk factors such as
occupational exposures dominate athero-
sclerosis in men, we would expect a smaller
effect signal and less precision in the estimates
among men. We also hypothesize that inter-
actions may reflect biologic causes. If pre-
menopausal women are protected against
atherosclerosis by endogenous hormones, loss
of hormonal protection would lead to
increased vulnerability after menopause
(Kannel et al. 1976). This could explain part
of the interaction by both age and sex.
Active and passive smoking did not con-
found results in either the total sample or
among subgroups. Adjustment for active
tobacco smoke led to a slight increase in the
effect estimate; thus, residual confounding is
unlikely to overestimate the effects. However,
PM2.5 associations were clearly stronger in
never smokers compared with smokers (data
not shown). This gradient was also observed
in all subgroups with signiﬁcant PM2.5 associ-
ations (Figure 3). Oxidative and inflamma-
tory effects of smoking may dominate to such
an extent that the additional exposure to
ambient air pollutants may not further
enhance effects along the same pathways. The
difference in the effects of PM2.5 in smokers
and nonsmokers needs further investigation.
The American Cancer Society cohort study
does not reveal a clear pattern of a smoking
interaction for the association of ambient air
pollution and cardiovascular death (Krewski
et al. 2004; Pope et al. 2004). In the Study on
Air Pollution and Lung Diseases in Adults
(SAPALDIA), associations between air pollu-
tion and level of pulmonary function did not
differ by smoking status (Ackermann-Liebrich
et al. 1997).
Some U.S. studies indicate effect modiﬁca-
tion of air pollution by socioeconomic status
(SES) with much stronger effects among the
less educated (Pope et al. 2002). The cause of
this interaction pattern is not well understood.
SES status was rather homogeneous in these
mostly well-educated volunteers, providing lit-
tle power to investigate interactions of pollu-
tion with SES. If lower SES also positively
modifies effects of air pollution on athero-
sclerosis, our population would provide an
underestimate of the health effects in the gen-
eral population (O’Neill et al. 2003). Further
research on samples representative of the popu-
lation will be needed to assess whether the high
SES in the clinical trials biases the effects
toward the null.
Future research should focus on identify-
ing factors that determine susceptibility to
PM2.5. We are initiating studies on subjects
with inflammatory metabolic syndromes
prone to accelerated atherosclerosis such as
postmenopausal women, diabetics, or obese
or physically inactive people. To corroborate
the cross-sectional ﬁndings, follow-up studies
are ultimately needed to investigate the associ-
ation of concurrent levels of air pollution
exposure with the progression of CIMT.
Plausibility. From a biologic perspective,
our results support the hypothesis that long-
term exposure to ambient PM contributes to
systemic inﬂammatory pathways, which are a
relevant aspect of atherogenesis (Ross 1999).
The ﬁndings indicate a biologically plausible
link between the observed acute effects of
ambient air pollution on systemic inﬂamma-
tion (Glantz 2002) and the long-term conse-
quences of sustained vascular inflammation
leading to increased atherosclerosis and, ulti-
mately, cardiovascular death (Hoek et al.
2002; Pope et al. 2004). Among susceptible
people, this may lead to artery wall lesions
similar to those observed in the rabbit model
(Fujii et al. 2002; Suwa et al. 2002). In these
hyperlipidemic rabbits, 4-week PM exposure
was associated with the progression of athero-
sclerotic lesions, coupled with an enhanced
release of bone marrow monocytes. These pre-
cursors of macrophages play an important role
in the atherogenic inflammatory responses
(Goto et al. 2004; Ross 1999; Suwa et al.
2002). Given the central role of oxidized LDL
in the initiation and progression of athero-
genesis, suggestions that the plasma of auto-
motive workers with high exposure to trafﬁc
exhaust is more susceptible to oxidation is also
of interest (Sharman et al. 2002).
As a quantitative plausibility check, we
compared the size of the PM2.5 effects with
effects of other risk factors on CIMT. Using
smoking and environmental tobacco smoke
(ETS) as a model for air pollution exposure,
the size of our estimates appear plausible
(Diez-Roux et al. 1995; Howard et al. 1994).
Associations of ETS and current levels of air
pollution with various respiratory outcomes
are similar and support the notion of com-
mon underlying pathways (Künzli 2002).
Smoking and ETS associate with stiffer and
thicker artery walls, reflecting the systemic
effect of these exposures (Howard et al. 1994;
Mack et al. 2003). Exposure to ETS was asso-
ciated with 2–3% thicker intima-media,
which approximate the effects observed for a
10 µg/m3 change in PM2.5 (Diez-Roux et al.
1995; Howard et al. 1994). Using never
smokers without ETS exposure as the referent
group in our data, never smokers with ETS at
home had 0.9% (–2.7 to 4.5%) thicker artery
walls; former smokers’ CIMT was increased
on average by 3.4% (0.7–6.3%), and the
30 current smokers had 5% (–1.5 to 11.6%)
thicker CIMT. The trend across these four
categories of tobacco exposure was statistically
significant. As shown in Table 1, smokers
were underrepresented in these volunteers of
well-educated participants.
The observed percent change in CIMT
corresponds to an increase in the thickness of
approximately 20–40 µm per 10 µg/m3 con-
trast in PM2.5. This difference in CIMT trans-
lates into some 3–6% increase in the long-term
risk for myocardial infarction (O’Leary et al.
1999). Pope et al. (2004) reported that long-
term exposure to PM2.5 was associated with an
18% (14–23%) increase in ischemic heart dis-
ease. Effect sizes reported here concur with
these ﬁndings, indicating that a fraction of the
total effect of ambient PM on cardiovascular
mortality may be mediated through sustained
long-term effects of air pollution on athero-
sclerosis (Künzli et al. 2001). This is in line
with the proposed model (Künzli et al. 2001)
in which some of the effects observed in cohort
studies must reﬂect long-term contributions of
air pollution to the underlying disease progres-
sion, whereas in other cases, air pollution con-
tributes only to triggering of cardiovascular
events or death (Bell et al. 2004; Künzli et al.
2001; Peters and Pope 2002).
From a biologic and policy perspective, we
emphasize that PM2.5 probably serves as a sur-
rogate for the mixture of urban air pollution
and constituents of PM. It is premature to
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the atherogenic culprit per se. Atherosclerosis
results from complex processes that may
include a combination of various urban pollu-
tants, host factors, and pathways that ulti-
mately lead to the ﬁndings of a CIMT–PM2.5
association.
In conclusion, we have presented the ﬁrst
epidemiologic evidence supporting the idea of
a chronic vascular response to respiratory and
systemic effects of PM exposure. Given the
leading role of heart disease as a cause of death
in most westernized countries and the growing
contribution in developing countries, these
findings may be of high public health rele-
vance. Further investigations need to focus on
susceptible groups and follow-up of cohorts to
investigate the effect of air pollution on the
progression of CIMT.
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